Avalon GloboCare Corp.

0.4400-0.0301-6.40%Vol 110.49K1Y Perf -54.80%
Jun 24th, 2022 16:00 DELAYED
BID0.4111 ASK0.4700
Open0.4700 Previous Close0.4701
Pre-Market- After-Market0.44
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
     22.46
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
4.99 
Earnings Rating
Neutral
Market Cap39.14M 
Earnings Date
15th Aug 2022
Alpha0.06 Standard Deviation0.56
Beta0.81 

Today's Price Range

0.44000.4812

52W Range

0.40061.19

5 Year PE Ratio Range

-44.20-9.10

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
1.08%
1 Month
-12.80%
3 Months
-41.33%
6 Months
-52.17%
1 Year
-54.80%
3 Years
-80.87%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
AVCO0.4400-0.0301-6.40
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
0.10
0.20
0.72
2.63
-44.10
Leverage Ratio 4.30
ProfitabilityValueIndustryS&P 500US Markets
30.10
-614.70
-582.40
-735.70
-
RevenueValueIndustryS&P 500US Markets
1.40M
0.02
-3.60
10.42
Earnings HistoryEstimateReportedSurprise %
Q03 2021--0.02-
Q02 2021--0.03-
Q01 2021--0.03-
Q02 2020--0.04-
Q01 2020--0.04-
Q03 2019--0.04-
Q02 2019--0.06-
Q01 2019--0.06-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date15th Aug 2022
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume110.49K
Shares Outstanding88.96K
Shares Float32.41M
Trades Count270
Dollar Volume50.16K
Avg. Volume69.67K
Avg. Weekly Volume71.51K
Avg. Monthly Volume56.92K
Avg. Quarterly Volume80.58K

Avalon GloboCare Corp. (NASDAQ: AVCO) stock closed at 0.44 per share at the end of the most recent trading day (a -6.4% change compared to the prior day closing price) with a volume of 110.49K shares and market capitalization of 39.14M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 10 people. Avalon GloboCare Corp. CEO is David Jin.

The one-year performance of Avalon GloboCare Corp. stock is -54.8%, while year-to-date (YTD) performance is -46.34%. AVCO stock has a five-year performance of %. Its 52-week range is between 0.4006 and 1.19, which gives AVCO stock a 52-week price range ratio of 4.99%

Avalon GloboCare Corp. currently has a PE ratio of -4.40, a price-to-book (PB) ratio of 30.24, a price-to-sale (PS) ratio of 27.68, a price to cashflow ratio of 2 742.70, a PEG ratio of 2.32, a ROA of -83.94%, a ROC of -130.01% and a ROE of -296.72%. The company’s profit margin is -%, its EBITDA margin is -582.40%, and its revenue ttm is $1.40 Million , which makes it $0.02 revenue per share.

Of the last four earnings reports from Avalon GloboCare Corp., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Avalon GloboCare Corp.’s next earnings report date is 15th Aug 2022.

The consensus rating of Wall Street analysts for Avalon GloboCare Corp. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Avalon GloboCare Corp. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Avalon GloboCare Corp. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Avalon GloboCare Corp. has a Sell technical analysis rating based on Technical Indicators (ADX : 26.55, ATR14 : 0.05, CCI20 : -83.78, Chaikin Money Flow : -0.33, MACD : -0.03, Money Flow Index : 22.99, ROC : -21.71, RSI : 40.02, STOCH (14,3) : 13.79, STOCH RSI : 0.67, UO : 34.49, Williams %R : -86.21), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Avalon GloboCare Corp. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating-
0.00
-
0.00
-
0.00

Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promote and empower high impact, transformative biotechnology, and their clinical applications, and healthcare facility management. It has three reportable segments: real property operating segment which is the key revenue driver; medical-related consulting services segment; and development services and sales of developed products segment. The company focuses on the diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

CEO: David Jin

Telephone: 1 (732) 780-4400

Address: 4400 Route 9 South, Freehold 07728, NJ, US

Number of employees: 10

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

59%41%

Bearish Bullish

66%34%

Bearish Bullish

59%41%

News

Stocktwits